Physician profile
Robert H Lewe
NPI 1649387226
$2,557.37
in general payments reported to CMS, 2019-2025
23 companies · $331 in 2025
The $331 reported for 2025 was less than what a typical Urology provider received nationally (typical 2025 total: $631).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $220 · 2020: $356 · 2021: $339 · 2022: $127 · 2023: $188 · 2024: $996 · 2025: $331.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $994 · Travel and Lodging: $521.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $994.19 |
| Travel and Lodging | $521.04 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Procept Biorobotics Corporation | $803.93 | 2024 | Aquabeam System |
| Astellas Pharma US INC | $297.12 | 2019-2023 | Myrbetriq |
| Sumitomo Pharma America, INC. | $228.87 | 2023-2025 | Gemtesa |
| Lumenis, INC | $189.67 | 2020-2021 | |
| Boston Scientific Corporation | $187.07 | 2019-2025 | Ams 700, Lumenis Pulse 120h, Lithovue |
| Janssen Biotech, INC. | $127.37 | 2021-2025 | Erleada |
| Urogen Pharma, INC. | $96.73 | 2024-2025 | |
| 180 Medical, INC. | $85.28 | 2019-2022 | |
| Abbvie INC. | $69.70 | 2019-2025 | |
| Olympus America INC. | $62.79 | 2019-2020 | |
| Tolmar Pharmaceuticals, INC. | $61.57 | 2020-2021 | |
| Axonics, INC. | $53.33 | 2020-2022 | |
| Medtronic USA, INC. | $52.33 | 2019-2020 | |
| Endo Pharmaceuticals INC. | $45.76 | 2019-2021 | |
| Coloplast Corp | $36.73 | 2024-2025 |
Show all 23 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Endo USA, INC. | $30.15 | 2025 | Xiaflex |
| Urovant Sciences INC | $24.38 | 2021-2022 | |
| Photocure INC | $23.77 | 2025 | Cysview |
| Valencia Technologies Corporation | $20.63 | 2025 | Ecoin Device Kit |
| Progenics Pharmaceuticals, INC. | $17.86 | 2024 | |
| Tolmar, INC. | $16.18 | 2024 | |
| Calyxo, INC. | $14.55 | 2025 | Cvac Aspiration System |
| Janssen Pharmaceuticals, INC | $11.60 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Robert Lewe listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.